Omega 3 and antidepressants may help prevent dementia and depression

February 24, 2014 by Rachel Gleeson, University of Sydney

A University of Sydney study is looking into the effectiveness of omega-3 supplements and the antidepressant, sertraline, in reducing depressive symptoms and cognitive decline in older people, in a bid to prevent the onset of depression and dementia in later life.

The research, led by the University's Brain and Mind Research Institute (BMRI),is evaluating the effects of the two substances in preventing degenerative changes in , based on the abundance of literature linking with changes in the brain's blood vessels, oxidative stress and with other factors that are known to be protective for the brain.

Depression and anxiety affects three million Australians every year, and between 10 and 15 percent of older people experience depression, while around 10 per cent experience anxiety. Rates of depression among people living in residential aged-care facilities are believed to be much higher, at around 35 per cent.

Alarmingly, one in 10 Australians aged 65 and over had dementia in 2011, while three in 10 Australians aged 85 and over had dementia in 2011. An estimated 322,000 Australians were estimated to have dementia in 2013. Based on projections of population ageing and growth, the number of people with dementia will reach almost 400,000 by 2020, and around 900,000 by 2050.

Study lead, Associate Professor Sharon Naismith, said the work was one of very few projects in the world looking into ways to prevent onset of depression and dementia in older populations.

"Over the last decade, our BMRI team has demonstrated that the cognitive, brain scanning (MRIs) and clinical features of late-life depression are linked with brain disease and cognitive decline," she said.

"These changes are in turn linked to disability, functional decline and progression to dementia.

"Importantly, in older people can now be detected earlier, through the tracking of , and there is recognition internationally that prevention trials are now urgently warranted."

The study utilises the "Beyond Ageing cohort", a group of older persons with depressive symptoms who are scanned regularly through MRIs. The first group of 60 older adults 'at-risk' of depression were randomised to receive either omega 3 supplementation or placebo for 12-weeks.

Participants underwent MRI brain imaging, medical and neuropsychological assessments at the start of the trial and again after 12-weeks of supplementation. The results showed that participants taking the placebo had greater brain matter changes (specifically glutathione/creatine ratio in the thalamus) after the 12-week intervention, which, correlated with increased severity of depressive symptoms.

"Our findings offer promise for the prevention of depression in and the brain changes leading to depression, cognitive decline and ," Associate Professor Naismith said.

"We are not always sure what brain white matter change is due to but they can be due to vascular damage (from hypertension, high cholesterol, heart disease) or could instead be inflammatory. The presence of such changes on MRI is commonly seen in people who have depression in later life.

"We hope that the use of fish oils will stabilise this inflammation and support the vascular system, thereby also preventing depression and ."

Explore further: Study finds late-life depression associated with increased risk for dementia

Related Stories

Study finds late-life depression associated with increased risk for dementia

May 2, 2013
(Medical Xpress)—Late-life depression is associated with an increased risk for all-cause dementia, Alzheimer's disease and, most predominantly, vascular dementia, according to the results of a new meta-analysis published ...

Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia

December 31, 2012
Depression in a group of Medicare recipients ages 65 years and older appears to be associated with prevalent mild cognitive impairment and an increased risk of dementia, according to a report published Online First by Archives ...

Heart disease linked with dementia in older postmenopausal women

December 18, 2013
Heart disease may put older postmenopausal women at higher risk for decreased brain function such as dementia, according to new research in Journal of the American Heart Association.

New treatment hope for menopausal depression

August 19, 2013
A trial involving middle-aged Australian women is investigating the use of a hormone treatment for symptoms of menopausal depression.

Brain atrophy linked with cognitive decline in diabetes

September 12, 2013
New research has shown that cognitive decline in people with Type 2 Diabetes is likely due to brain atrophy, or shrinkage, that resembles patterns seen in the early stages of Alzheimer's disease.

Regular physical activity reduces risk of dementia in older people

November 1, 2012
Regular physical activity may help older people reduce their chances of getting dementia.

Recommended for you

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

Mice with frequent flier miles advance the Alzheimer's cause

January 4, 2018
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.